JBS SCIENCE INC — Department of Health and Human Services SBIR Phase I: 172

Description

DESCRIPTION provided by applicant This SBIR phase I application is being submitted in response to the Program Announcement PAR entitled andquot Methods of Development for Obtaining Comprehensive Genomic Information from Human Specimens that are Easy to collect and store andquot This proposal specifically addresses the request for sensitive and cost effective technologies for obtaining high quality and comprehensive genomic data from urine which is both an easy to collect and easy to handle form of human specimen We have already developed the standard operating procedures SOP to collect urine for genetic studies which can be used for research purposes that have been implemented in the NCI EDRN funded validation study protocol ID We have also developed a patented fractionation method that enables us to separate the DNA into two distinct species based on fragment sizes DNA larger than kb is designated as high molecular weight HMW DNA which is mostly derived from the cell debris of the urinary tract Conversely the DNA ranging from to bp is designated as low molecular weight LMW DNA which is derived mostly from the circulation We have shown that LMW DNA can be used for the detection of circulation derived genetic markers of cancer if the tumor is present In phase I Aim of this application is to demonstrate that HMW urine DNA can replace whole blood as a DNA source for obtaining comprehensive and high quality genomic information We will also demonstrate that LMW urine DNA can be a source for cell free apoptotic DNA for detecting somatic acquired genetic variants from the entire body similar to plasma DNA Aim We propose to use TP codon mutations as a somatic mutation marker to compare the LMW urine DNA and plasma DNA for the sensitivity of detecting circulation derived mutations In phase II we propose to develop the urine DNA collection kit JBS Hi Lo urine DNA kit to optimize the use of urine which is both easy to collect and easy to handle including sample transportation and storage for clinical use It is anticipated that this proposal will lead to the development of a kit that will provide a complete end to end solution that addresses all the steps from sample collection and nucleic acid extraction to sequencing for obtaining complete genomic information with various applications in both clinic and research PUBLIC HEALTH RELEVANCE With advancing genomic technologies and simultaneous falling costs of whole genome sequencing and analysis there is an opportunity to enhance clinical and public health value of genetic tests by expanding them to deliver comprehensive genomic data from human specimens that are easy to collect and handle We propose our method of using urine DNA which is absolutely non invasive and is of particular value in remote and under sourced environments The goal of this project is to develop the JBS Hi Lo urine DNA kit that will provide a complete end to end solution to address all the steps from sample collection and nucleic acid extraction to next generation sequencing NGS for obtaining complete genomic information for various applications in clinic and research